Genesis of Prevention
Tuesday, May 10, 2022
Partnership and community are central to Capital Factory’s mission, so it’s only fitting that two essential partners help us open the inaugural Health Supernova. As longtime leaders at title sponsors UT Dallas and UT Southwestern Medical Center, Drs. Pancrazio and Nivet will bring their seasoned perspectives to discuss the revolutionary growth driving biotech innovation across the state…and far beyond.
Hear their first-hand experiences in accelerating critical health research and technology development and the focal areas that are changing the face of healthcare and biotech. Walk away with insight on national healthcare and biotech priorities and the driving forces for investment and innovation across the health ecosystem.
The warp speed of technology advancement across healthcare is driving a convergence of innovation and impact on how patients are treated. Hear from three esteemed thought leaders and innovators in biotech+ today who are developing and investing in the technologies to define the future.
Amy Kruse brings insightful perspective on human 2.0 technology and robotics in medical devices that are revolutionizing surgery, prosthetics, imaging, and other critical areas. Claire Aldridge clarifies the post-pandemic opportunities to enable biotech-based therapies that prevent and treat disease. Lauren Tyra covers the waterfront of technologies that enable greater accessibility and equity in healthcare systems. Expect to learn about what matters in healthcare today… and what’s next.
“No pain, no gain” is meant to console and motivate. Yet, for millions who live with unrelenting debilitating conditions, they’d do anything to gain relief. Opioids can’t be the only answer. Every day in America, three people die every hour from opioid overdose. Prescription opioid misuse alone costs the U.S. $78.5B a year for healthcare, addiction treatment, and more. Physicians need other options and other prospects to help patients manage their pain.
CEO Candler Paige is on a mission to help. Her company, Doloromics, is building a proprietary platform for discovery of disease-specific pain mechanisms, biomarkers, and therapeutics to treat inflammatory and chronic pain. It will be a game-changer for getting quick chronic pain relief to patients who suffer from migraine, muscle pain, and neuropathies — common problems that require uncommon solutions.
What began as endless battles with action figures is now an endless and inspiring crusade to prevent and fight disease. In this Lightning Talk, two brothers at UTSW Medical Center —one an Infectious Disease expert trained at NIH, the other a Johns Hopkins-trained Neuroimmunologist—are on separate but driven paths.
Meet Dr. David Greenberg who is focused on commercializing precision pathogen-specific antibiotics to help tackle the worldwide crisis of antibiotic resistance. And learn about Dr. Ben Greenberg’s efforts for the Department of Neurology in treating rare autoimmune disorders of the central nervous system.
How are the genomes of mammoths different from their closest living relatives? And what genetic changes impact physical and adaptive traits? These are the types of questions bioinformaticians seek to answer by using next-gen tools to help design, execute, and validate biological experiments. And they’re questions that Brandi Cantarel and Colossal are answering to turn back time and revive the wooly mammoth. But it's not just about the species; this set of tools can be used for many purposes, whether it’s de-extinction or re-coding the human genome
In this quick talk, Brandi will outline how Colossal is pioneering CRISPR technology for the purposes of species de-extinction, beginning with the wooly mammoth. She and her team are combining the science of genetics with the business of discovery in an endeavor to jumpstart nature’s ancestral heartbeat and advance the economies of biology and healing through genetics.
Lightning Talk | Ending the Antibiotic Abuse presented by University of North Texas Health Science Center at Fort Worth
80% of patients are prescribed antibiotics for sinusitis, yet 90% of the time, sinusitis is caused by a viral infection that is untreatable by antibiotics. Together Entvantage Dx can reduce the use of antibiotics for ear, nose, and throat illnesses. Entvantage Dx diagnostic tests accurately distinguish bacterial from viral infections, reducing the unnecessary prescription of antibiotics. Joe Skraba will talk about their revolutionary diagnostic kit can qualitatively identify the three major bacterial sinusitis pathogens and provide differentiation from viral sinusitis infections. This determination allows the physician to only prescribe antibiotic treatment for patients who have bacterial sinusitis.
Social Determinants of Health in the Age of Digital Health Care presented by BlueCross BlueShield of Texas | C1 Innovation Lab
As technologies rise to improve healthcare, so too must our societal approaches to ensure all have equitable access to optimal healthcare, as well as access to key social and community services that contribute to positive health outcomes.
All of us, from clinicians to business executives, technologists, and community leaders each play an important role in impacting the social determinants of our society.
Join Dr. Madhuri Bobba and Dr. Claire Aldridge for a discussion about how technologies and social systems can work together to help people thrive in their health and lives.
InspectIR has created breath analysis technology for portable COVID-19 diagnostic screening applications. InspectIR is the only testing methodology that does not create cross-reactivity, which leads to pre-analytical error, based on adding a solvent or another reagent to bind to a specimen for analysis. InspectIR is the first company to make a commercially available miniature mass spectrometer to analyze breath samples directly.
Weighing in at just three pounds, the human brain is the marvelous, mysterious source of everything that defines us as humans. It’s also been the modern medical mystery for centuries, and only in the last 10 years or so has scientific research yielded important insights and answers. Now, as technology development accelerates, exciting breakthroughs in neurological and behavioral science are possible.
That’s welcome news for more than 700,000 Americans living with a primary brain tumor. While most brain tumors are not malignant, the impact of treatment is likely life-changing. Dr. Darin Okuda and his team at UT Southwestern Neurology are working to change these realities, with a better way to diagnose and treat brain tumors using 3-D printing. As the keynote speaker for our Genesis of Prevention track at Health Supernova, presented by The University of Texas at Dallas and UT Southwestern Medical Center, Dr. Okuda will share how it works — and how it can scale.
Together with BioLabs, McKesson, and BCBSTX C1 Innovation Lab, we are excited to announce a healthcare investment showcase at Health Supernova 2022!
Five of the hottest healthcare startups in Texas will showcase to an audience of healthcare professionals, investors, and entrepreneurs live at Pegasus Park and online from around the world to be considered for up to $100,000 in investment and a fast track to join Capital Factory.